Impact of the app-based and nurse-led supportive care program AKO@dom on dose intensity of oral-targeted therapies in patients with metastatic renal cell cancer: a multicentric observational retrospective study

Background Tyrosine kinase inhibitors (TKIs) remain a cornerstone of metastatic kidney cancer (mRCC). Adverse events (AEs) may lead to dose downregulation, and optimal management of AEs is needed to maintain an efficient dose intensity (DI). The aim of our study was to evaluate the impact of an app-...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Supportive care in cancer Jg. 30; H. 8; S. 6583 - 6591
Hauptverfasser:	Gaillard, Victor, Lhuillier, Albane, Bigot, Cécile, Pierard, Laure, Trensz, Philippe, Burgy, Mickael, Schuster, Caroline, Malouf, Gabriel, Fritsch, Aurélie, Lang, Hervé, Tricard, Thibault, Borchiellini, Delphine, Geoffrois, Lionnel, Barthelemy, Philippe
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Berlin/Heidelberg Springer Berlin Heidelberg 01.08.2022 Springer Springer Nature B.V
Schlagworte:	Antimitotic agents Antineoplastic agents Cancer Care and treatment Chemotherapy Clinical research Clinical trials Complications and side effects Critical incidents Discontinued Dosage Drug dosages Elementary school students Inhibitor drugs Kidney cancer Medical personnel Medical treatment Medicine Medicine & Public Health Metastasis Nurse led services Nurses Nursing Nursing care Nursing Research Oncology Oncology, Experimental Oral administration Original Article Pain Medicine Palliative care Patients Rehabilitation Medicine Side effects Targeted cancer therapy App-based program TKI Supportive care program Nurse-led program Kidney cancer
ISSN:	0941-4355, 1433-7339, 1433-7339
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!